OSE Immunotherapeutics SA at its General Shareholders' Meeting approved the nominations of two new independent Directors, Brigitte Dréno, M.D., Ph.D., and Diane Kathryn Jorkasky, M.D. Brigitte Dréno, M.D., Ph.D., is head of the Department of Dermatology at the Nantes University Hospital. She is the director of the Biotherapy Clinical Investigation Centre, director of the Unit of Cell and Gene Therapy and vice dean for Research Medical Faculty. Diane Kathryn Jorkasky, M.D., has over 20 years of pharmaceutical and biotechnology experience in medical and scientific leadership positions with Endo Pharmaceuticals, Pfizer and GSK. She has extensive knowledge of and experience in all phases of drug research and development.